ENHANCING THE QUALITY OF LIFE OF PATIENTS WITH GLAUCOMA:
A WORLD OF INDIVIDUALS

Scientific Symposium
October 3-4, 2003
Philadelphia, Pennsylvania

The world-wide effects of glaucoma - Rohit Varma

Narrow angles and angle-closure: The leading cause of permanent blindness. Is appropriate treatment lens extraction, iridoplasty, iridotomy, or something else? - Nathan Congdon

Prevalence of so-called secondary glaucomas: The consequences of ignoring their malignance – what is essential to know and do! - Marlene Moster

Essential outcome measures are not acuity, field, or pressure but rather are performance (AFREV) and quality of life - Mark Sherwood

The goal is improvement: Saludogenesis - Mark Lesk

Evidence that studying vascular considerations can benefit patients with glaucoma - Alon Harris

Constitutional risk factors for nerve damage and possible therapeutic implications - Joseph Caprioli

What the competent clinician must know about genetics - Lee Alward

          Glaucoma Genetics Scorecard - 2003 - Lee Alward

“Nature-Nurture”: More of a concern than ever! - Jon Polansky

Ocular risk factors for blindness from glaucoma - Louis Cantor

Socioeconomic risk factors for visual loss and decrease in quality of life - Eve Higginbotham

Various courses of the open-angle glaucomas: Relationship to intraocular pressure - Roger Hitchings

The optic disc: That which must be understood in glaucoma and the Disc Damage Likelihood Scale - Jeffrey Henderer

Evaluation of the retinal nerve fiber layer in glaucoma - Neil Choplin

The topography of the optic nerve and retina: What’s hot - Joel Schuman

The proper image of image analyzers: What’s important - Jonathan Myers

Thinking out of the box: The lesson and promise of corneal thickness - James Brandt

Putting it all together practically: History, angle, risk factors, disc, and the individual Glaucoma Graph - George Spaeth

We need more randomized, long-term, controlled studies: Important lessons from the GLT, AGIS, CIGTS, OHTS, etc - Richard Parrish

“Until the middle of the 19th Century the likelihood that an individual would be benefited from an encounter with a physician was about 50 percent.” This old statement is still not far from the truth – implications for approaches to treatment today - Clive Migdal

The wonderful new drugs have made a difference – better and worse! - Ronald Gross

Surgery - Peng Khaw

Argon Laser Trabeculoplasty and Selective Laser Trabeculoplasty: underutilized treatments - Jay Katz

Flat anterior chambers, postoperative cataracts and failing blebs are no longer acceptable; avoid them with releasable sutures, minimal hypotony, individualized operative and postoperative management with appropriate antifibrotic care, avoiding mitomycin C - Peng Khaw

The new frontier is coming: Genetic testing, pharmacogenetics and gene therapy - Douglas Rhee

Challenges for the future can be met if the world of medicine and the culture of the world are understood - M. Bruce Shields

Spreading and hearing the word: Scientific, economic, and ethical dimensions - Vital Costa

An upstate medical practice - Lorenzo Pecora

Problems in an area where resources are limited - Tarek Eid

Problems and solutions in Turkey - Atilla Bayer

Are new remedies found in old approaches? - Youqin Jiang

Reaching consensus: lessons from the European Glaucoma Society "Terminology and Guidelines" Project - Carlo Traverso